Alkermes PLC | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
577,213.20
618,789.00
628,335.00
745,694.00
903,374.00
1,094
Cost of Goods Sold (COGS) incl. D&A
230,311.40
242,185.00
202,874.00
200,981.00
227,307.00
253
Gross Income
346,901.80
376,604.00
425,461.00
544,713.00
676,067.00
841
SG&A Expense
326,243.20
463,748.00
649,762.00
753,378.00
823,967.00
934
EBIT
20,658.60
87,144.00
224,301.00
208,665.00
147,900.00
93
Unusual Expense
300.00
-
2,300.00
7,900.00
11,100.00
28
Non Operating Income/Expense
972.00
84,573.00
12,513.00
2,485.00
885.00
2
Interest Expense
13,838.60
13,430.00
13,247.00
14,889.00
12,008.00
13
Pretax Income
7,096.00
14,029.00
224,005.00
214,387.00
143,274.00
127
Income Tax
16,336.00
16,032.00
3,158.00
5,943.00
14,671.00
12
Consolidated Net Income
23,431.90
30,061.00
227,163.00
208,444.00
157,945.00
139
Net Income
23,431.90
30,061.00
227,163.00
208,444.00
157,945.00
139
Net Income After Extraordinaries
23,431.90
30,061.00
227,163.00
208,444.00
157,945.00
139
Net Income Available to Common
23,431.90
30,061.00
227,163.00
208,444.00
157,945.00
139
EPS (Basic)
0.16
0.21
1.52
1.38
1.03
0.90
Basic Shares Outstanding
135,960.00
145,274.00
149,206.00
151,484.00
153,415.00
155
EPS (Diluted)
0.16
0.21
1.52
1.38
1.03
0.90
Diluted Shares Outstanding
144,961.00
145,274.00
149,206.00
151,484.00
153,415.00
155
EBITDA
115,011.70
10,943.00
138,705.00
114,409.00
49,377.00
10
Non-Operating Interest Income
948.00
1,972.00
3,330.00
3,752.00
4,649.00
9

About Alkermes

View Profile
Address
Connaught House
Dublin Dublin D04 C5Y6
Ireland
Employees -
Website http://www.alkermes.com
Updated 07/08/2019
Alkermes Plc IS a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. It operates through the following geographical segments: U. S.